Jair Bar, M.D., Ph.D.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib (NCT06206850) | Jair Bar, M.D., Ph.D. | 2024-02-19 |
| Anti PD-1 Neo-adjuvant Treatment for NSCLC (NCT02938624) | Jair Bar, M.D., Ph.D. | 2017-01-07 |
Track Jair Bar, M.D., Ph.D. automatically
Every clearance here is in the API, with alerts when new ones post.